AFG206 is a novel, first-generation type II FLT3 inhibitor for research use. It potently targets both wild-type and mutant FLT3, showing efficacy in cellular assays and in vivo models of acute myeloid leukemia (AML). This compound is a valuable tool for investigating FLT3-driven oncogenesis and therapeutic strategies.
Molecular Weight:
333.38
CAS Number:
[630122-37-1]
Formula:
C20H19N3O2
Target:
Apoptosis,FLT,Others
* VAT and and shipping costs not included. Errors and price changes excepted
